Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
EPS (Diluted)
Tibet Rhodiola Pharmaceutical Holding Co
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
EPS (Diluted)
¥3
|
CAGR 3-Years
24%
|
CAGR 5-Years
30%
|
CAGR 10-Years
37%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
EPS (Diluted)
¥2
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
EPS (Diluted)
¥1
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
2%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
EPS (Diluted)
¥2
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
Huadong Medicine Co Ltd
SZSE:000963
|
EPS (Diluted)
¥1
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
16%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's EPS (Diluted)?
EPS (Diluted)
3.2
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's EPS (Diluted) amounts to 3.2 CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
37%
Over the last year, the EPS (Diluted) growth was 117%. The average annual EPS (Diluted) growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 24% over the past three years , 30% over the past five years , and 37% over the past ten years .